A-Z guide
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
- A possible framework for a joint trans-tasman agency to regulate therapeutic goods (including New Zealand healthcare products) (June 2000)
- A proposal for a trans Tasman agency to regulate therapeutic products (June 2002)
- About the trans Tasman therapeutic products agency project
- Accountability, structure and governance arrangements for the new Authority
- Administration Rule - draft (May 2006)
- Advertising
- Description of the joint regulatory scheme for the advertising of therapeutic products (includes the Australian New Zealand Therapeutic Products Advertising Code)
- Development of a trans Tasman advertising scheme for therapeutic goods
- Advertising Implementation Steering Group
- ANZTPA-UPDATE email list
- Assessment of regulatory options for therapeutic products - report to the trans-Tasman working group (October 2002)
- Australia and New Zealand agree on a joint committee to oversee standards for therapeutic products (media release, 5 May 2005)
- Australia and New Zealand medicine labelling requirements are currently underway (media release, 1 June 2004)
- Australia and New Zealand move closer to establishing joint therapeutic products authority (media release, 22 March 2006)
- Australia and New Zealand sign treaty to regulate medicines and therapeutic products (media release, 10 December 2003)
- Australian Bill: Therapeutic Products Bill 2007 - Exposure Draft (Department of Health & Ageing website)
- Australian Government response to the recommendations of the Expert Committee on Complementary Medicines in the Health System
- Australian review of policy framework for regulating products at the cosmetic/therapeutic interface
- Australian treaty examination process (Parliament of Australia Joint Committee, 30 March 2004) (includes a Regulation Impact Statement and National Impact Analysis on the Agreement between Australia and New Zealand for the Establishment of a Joint Scheme to Regulate Therapeutic Products)
B
- Best practice guideline on prescription medicine labelling (draft)
- Bills
- Australia: Therapeutic Products Bill 2007 - Exposure Draft (Department of Health & Ageing website)
- New Zealand: Therapeutic Products and Medicines Bill (New Zealand Parliament website)
- Blood regulation to be included in new Australia/New Zealand therapeutic products agency (media release, 10 May 2004)
C
- Child-resistant packaging requirements for therapeutic goods
- Clinical trials
- COMET (Complementary medicines transition database)
- Committees
- Complementary medicines
- How would the new Authority and proposed joint regulatory scheme affect Māori?
- Complementary medicines information sessions (January & February 2005)
- Complementary medicines transition database (COMET)
- Information sessions on the proposed regulation of homoeopathic and anthroposophic medicines, and essences, in the Australia New Zealand Therapeutic Products Authority (ANZTPA) (11 & 13 July 2006)
- Interim Joint Expert Advisory Committee on Complementary Medicines
- Permitted ingredients list project
- Proposed regulatory definitions for complementary medicines and homoeopathic medicines in a joint Australia New Zealand therapeutic products agency
- Regulation of complementary medicines in Australia - a positive story
- Regulation of herbal substances in a joint Australia New Zealand therapeutic products agency
- Regulation of homoeopathic and related medicines in a joint Australia New Zealand therapeutic products agency
- The proposed joint regulatory scheme for complementary medicines
- Transition to the joint regulatory scheme for complementary medicines
- Consultation begins on proposed Australia New Zealand Therapeutic Products regulatory scheme (media release, 23 May 2006)
- Cosmetics
D
- Description of the joint regulatory scheme for the advertising of therapeutic products (includes a copy of the Australian New Zealand Therapeutic Products Advertising Code)
- Development of a trans Tasman advertising scheme for therapeutic goods
- Devices
- Discussion paper - Workflow practices within the Drug Safety and Evaluation Branch (DSEB) of the TGA
- Draft best practice guideline on prescription medicine labelling
- Draft labelling requirements for medicines under a joint Australia New Zealand therapeutic products agency
- Draft Administrataion Rule (May 2006)
- Draft Medical Devices Rule (May 2006)
- Draft Medicines Rule (May 2006)
E
- Email list ANZTPA-UPDATE
F
- Fact sheets
- Fees & charges - proposed (May 2006)
- Food - Guidance tool for assessing the appropriate regulatory coverage for products at the food-medicine interface
G
- Good manufacturing practice
- Governance, structure and accountability arrangements for the new Authority
- Government encourages moves to establish a joint therapeutic goods agency for Australia and New Zealand (media release, 5 July 2001)
- Grouping Order for medicines - proposed (May 2006)
H
- Harmonisation
- Herbal substances
- Homoeopathic medicines
- Information sessions on the proposed regulation of homoeopathic and anthroposophic medicines, and essences, in the Australia New Zealand Therapeutic Products Authority (ANZTPA) (11 & 13 July 2006)
- Proposed regulatory definitions for complementary medicines and homoeopathic medicines in a joint Australia New Zealand therapeutic products agency
- Regulation of homoeopathic and related medicines in a joint Australia New Zealand therapeutic products agency
- Also see: Complementary medicines
- Hui - consultation (held 10 July 2006)
I
- Improving access to prescription medicines information
- Information sessions on the proposed regulation of homoeopathic and anthroposophic medicines, and essences, in the Australia New Zealand Therapeutic Products Authority (ANZTPA) (11 & 13 July 2006)
- Interim Advertising Council
J
- Joint Australia and New Zealand Therapeutic Products Authority planned for next year (media release, 11 May 2006)
- Joint Expert Committee on Labelling Requirements for Medicines
- Joint Interim Expert Advisory Committee on Complementary Medicines
- Joint Interim Expert Advisory Committee on Standards
K
L
- Labelling
- Australia and New Zealand medicine labelling requirements are currently underway (media release, 1 June 2004)
- Draft best practice guideline on prescription medicine labelling
- Draft labelling requirements for medicines under a joint Australia New Zealand therapeutic products agency
- Joint Expert Committee on Labelling Requirements for Medicines
- Labelling requirements for medicines under the Australia New Zealand Therapeutic Products Authority - Report on stakeholder consultation and Revised Draft Managing Director's Order
- Licensing - draft guideline on transition provisions (May 2006)
M
- Manufacturing
- Medical devices
- Māori - How would the new Authority and proposed joint regulatory scheme affect Māori?
- Medicines Manufacturing Principles (May 2006)
- Medicines Rule - draft (May 2006)
- Medicines Grouping Order - proposed (May 2006)
- Medicines - Guidance tool for assessing the appropriate regulatory coverage for products at the food-medicine interface
- Medicines labelling
- Australia and New Zealand medicine labelling requirements are currently underway (media release, 1 June 2004)
- Draft best practice guideline on prescription medicine labelling
- Draft labelling requirements for medicines under a joint Australia New Zealand therapeutic products agency
- Labelling requirements for medicines under the Australia New Zealand Therapeutic Products Authority - Report on stakeholder consultation and Revised Draft Managing Director's Order
- Microbiological standards for medicines in the Australia New Zealand Therapeutic Products Authority (ANZTPA)
N
- New Australia-New Zealand Therapeutic Products Authority a step closer (media release, 27 March 2006)
- New initiatives for joint Australia / NZ agency (media release, 16 July 2004)
- New Zealand and Australia to consider joint medicines regulatory body (media release, 15 March 2001)
- New Zealand Bill - Therapeutic Products and Medicines Bill (New Zealand Parliament website)
- New Zealand National Interest Analysis on the Agreement Between the Government of Australia and the Government of New Zealand for the Establishment of a Joint Scheme for the Regulation of Therapeutic Products (March 2004)
- New Zealand Regulatory Impact Statement (September 2003)
- New Zealand Regulatory Impact Statement on a proposal for a trans Tasman agency to regulate therapeutic products (November 2002)
O
- Orders
- Over-the-counter (OTC) medicines
- Overview of the proposal to establish a trans-Tasman regulatory scheme for therapeutic products
P
- Permitted ingredients list project (complementary medicines)
- Pharmacopoeial standards for medicines in the Australia New Zealand therapeutic products agency (consultation paper)
- Plain English Guide on the proposed regulatory scheme outline in the draft Rules (May 2006)
- Prescription medicines
- Product licensing - draft guideline on transition provisions (May 2006)
- Proposed fees & charges (May 2006)
- Proposed NZ - Australia therapeutic products agency (media release, 7 June 2002)
- Proposed regulatory definitions for complementary medicines and homoeopathic medicines in a joint Australia New Zealand therapeutic products agency
Q
R
- Regulation of complementary medicines in Australia - a positive story
- Regulation of herbal substances in a joint Australia New Zealand therapeutic products agency
- Regulation of homoeopathic and related medicines in a joint Australia New Zealand therapeutic products agency
- Regulators Forum - Sydney November 2000
- Regulators Forum - Tokyo November 2002
- Regulatory arrangements for clinical trials and access to unapproved therapeutic products
- Regulatory impact
- Report on stakeholder comment in response to the Consultation Paper: A Possible Framework for a Joint Trans-Tasman Agency to Regulate Therapeutic Goods (Including New Zealand Healthcare Products)
- Rongoā - How would the new Authority and proposed joint regulatory scheme affect Māori?
S
- Stakeholder consultation programme 2006/07
- Standards
- Steady progress toward the Australia New Zealand Therapeutic Products Authority (media release, 11 December 2005
- Structure, governance and accountability arrangements for the new Authority
T
- The proposed joint regulatory scheme for complementary medicines
- Therapeutic Products Bill 2007 - Exposure Draft (Department of Health & Ageing website)
- Therapeutic Products and Medicines Bill (New Zealand Parliament website)
- Therapeutic Products Interim Ministerial Council (TPIMC)
- Steady progress toward the Australia New Zealand Therapeutic Products Authority (media release, 11 December 2005
- Australia and New Zealand agree on a joint committee to oversee standards for therapeutic products (media release, 5 May 2005)
- New initiatives for joint Australia / NZ agency (media release, 16 July 2004)
- Australia and New Zealand medicine labelling requirements are currently underway (media release, 1 June 2004)
- Blood regulation to be included in new Australia/New Zealand therapeutic products agency (media release, 10 May 2004)
- Transition to the joint regulatory scheme for complementary medicines
- Transition to the joint regulatory scheme for medical devices
- Transition to the joint regulatory scheme for prescription and over-the-counter medicines
- Treaty
U
- Unapproved therapeutic products
V
W
- Web assisted notification of devices (WAND)
- Website shares information about trans-Tasman proposal (media release, 3 October 2001)
- What are therapeutic products and how would they be regulated under the proposed joint scheme?
- Workflow practices within the Drug Safety and Evaluation Branch (DSEB) of the TGA (discussion paper)